Does Rallies show Form 4 insider transactions for MLAB?

Yes. Rallies tracks MLAB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MLAB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MLAB. It does not provide personalized investment advice.

MLAB (Mesa Laboratories Inc) Stock Analysis - Insider Trades

Mesa Laboratories Inc (MLAB) is a publicly traded Technology sector company. As of May 21, 2026, MLAB trades at $103.59 with a market cap of $559.50M and a P/E ratio of 153.44. MLAB moved +4.26% today. Year to date, MLAB is +19.20%; over the trailing twelve months it is -9.82%. Its 52-week range spans $55.45 to $155.12. Analyst consensus is buy with an average price target of $115.00. Rallies surfaces MLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MLAB stock inside the company?

Recent MLAB insider activity includes Ladiwala Shiraz Shabanali bought 3.50K, Capone Mark Christopher bought 1.30K, Tripeny R Tony bought 1.31K, Owens Gary M sold 1.94K, and Archbold Brian David sold 472. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MLAB Key Metrics

Key financial metrics for MLAB
Metric	Value
Price	$103.59
Market Cap	$559.50M
P/E Ratio	153.44
EPS	$0.67
Dividend Yield	0.16%
52-Week High	$155.12
52-Week Low	$55.45
Volume	28
Avg Volume	0
Revenue (TTM)	$247.54M
Net Income	$3.73M
Gross Margin	62.41%

Recent MLAB Insider Trades

Ladiwala Shiraz Shabanali bought 3.50K (~$252.81K) on Mar 10, 2026.
Capone Mark Christopher bought 1.30K (~$99.33K) on Mar 10, 2026.
Tripeny R Tony bought 1.31K (~$99.94K) on Mar 10, 2026.
Owens Gary M sold 1.94K (~$188.31K) on Jun 16, 2025.
Archbold Brian David sold 472 (~$45.84K) on Jun 16, 2025.

Latest MLAB News

Mesa Laboratories Declares $0.16 Quarterly Dividend Payable June 15 — Apr 2, 2026
Mesa Laboratories Appoints Dr. Siddhartha Kadia CEO Effective April 13, 2026 — Mar 9, 2026
Conestoga Exits Mesa Laboratories After Shares Fall 35.06% Over Year — Feb 20, 2026

MLAB Analyst Consensus

1 analysts cover MLAB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $115.00.

Common questions about MLAB

Who is trading MLAB stock inside the company?: Recent MLAB insider activity includes Ladiwala Shiraz Shabanali bought 3.50K, Capone Mark Christopher bought 1.30K, Tripeny R Tony bought 1.31K, Owens Gary M sold 1.94K, and Archbold Brian David sold 472. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MLAB?: Yes. Rallies tracks MLAB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MLAB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MLAB. It does not provide personalized investment advice.